Efficacy and Safety of Camrelizumab in Real-World Prospective Study

Clinical trial NCT04793139 · UNKNOWN

Trial details

NCT number: NCT04793139
Sponsor: Guangdong Association of Clinical Trials
Status: UNKNOWN
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer

Start date: 2021-04-01
Primary completion: 2024-06-30
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.